NIR-Responsive Methotrexate-Modified Iron Selenide Nanorods for Synergistic Magnetic Hyperthermic, Photothermal, and Chemodynamic Therapy

• Published in: ACS applied materials & interfaces 2024-05, Vol.16 (20), p.25622-25636
• Main Authors: Thirumurugan, Senthilkumar, Muthiah, Kayalvizhi Samuvel, Lin, Yu-Chien, Dhawan, Udesh, Liu, Wai-Ching, Wang, An-Ni, Liu, Xinke, Hsiao, Michael, Tseng, Ching-Li, Chung, Ren-Jei
• Format: Article
• Language: English
• Subjects: Animals; Biological and Medical Applications of Materials and Interfaces; Breast Neoplasms - drug therapy; Breast Neoplasms - pathology; Breast Neoplasms - therapy; Cell Line, Tumor; Female; Humans; Hyperthermia, Induced; Infrared Rays; Iron - chemistry; Methotrexate - chemistry; Methotrexate - pharmacology; Mice; Mice, Inbred BALB C; Mice, Nude; Nanotubes - chemistry; Photothermal Therapy; Selenium Compounds - chemistry; Selenium Compounds - pharmacology; Selenium Compounds - radiation effects
• ISSN: 1944-8244; 1944-8252
• DOI: 10.1021/acsami.3c18450

Breast cancer is a malignant tumor with a high mortality rate among women. Therefore, it is necessary to develop novel therapies to effectively treat this disease. In this study, iron selenide nanorods (FeSe2 NRs) were designed for use in magnetic hyperthermic, photothermal, and chemodynamic therapy (MHT/PTT/CDT) for breast cancer. To illustrate their efficacy, FeSe2 NRs were modified with the chemotherapeutic agent methotrexate (MTX). MTX-modified FeSe2 (FeSe2-MTX) exhibited excellent controlled drug release properties. Fe2+ released from FeSe2 NRs induced the release of •OH from H2O2 via a Fenton/Fenton-like reaction, enhancing the efficacy of CDT. Under alternating magnetic field (AMF) stimulation and 808 nm laser irradiation, FeSe2-MTX exerted potent hyperthermic and photothermal effects by suppressing tumor growth in a breast cancer nude mouse model. In addition, FeSe2 NRs can be used for magnetic resonance imaging in vivo by incorporating their superparamagnetic characteristics into a single nanomaterial. Overall, we presented a novel technique for the precise delivery of functional nanosystems to tumors that can enhance the efficacy of breast cancer treatment.